Results 201 to 210 of about 159,964 (350)

Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes, Rishi S. Kotecha, Derek J. Roebuck   +2 more
wiley   +1 more source

Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next? [PDF]

Cancers (Basel)
Ceniceros L, Torre M, Landa Magdalena A, Sangro P, Argemí J, D'Avola D, Sangro B, Ponz-Sarvisé M.   +7 more
europepmc   +1 more source

Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer. [PDF]

JCO Precis Oncol
Cowzer D, Darmofal M, Seier K, Thummalapalli R, Walch H, El Dika I, Khalil DN, Park W, Dhyani A, Yaqubie A, Shin P, Gholami S, Erinjeri J, Wei AC, Yeh R, Do RK, Basturk O, Shia J, Cercek A, Schram A, Chatila WK, Schultz N, O'Reilly EM, Gonen M, Berger MF, Solit DB, Abou-Alfa GK, Jarnagin W, Harding JJ.   +28 more
europepmc   +1 more source

Outcomes of Prophylactic Suction Drainage Using the Freka Nasojejunal Tube Compared to Free Drainage on Development of Upper Gastrointestinal Tract Anastomotic Leaks

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Upper gastrointestinal tract anastomotic leaks are associated with increased morbidity and mortality, especially in the 30‐day post‐operative period. Techniques to reduce tension at the anastomotic site have been postulated to reduce leak rates.
Ryan Teh, Daniel Lee, Shawn Poh, Carlos Cabalag, Andrew Hardley, Mohammed Ballal, Sanjeeva Kariyawasam   +6 more
wiley   +1 more source

Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)

, 2010
Daniele Santini, Gaia Schiavon, Bruno Vincenzi, Carol E. Cass, Enrico Vasile, Andrea D. Manazza, V. Catalano, Giacomo Giulio Baldi, Rai‐Hua Lai, Stefania Rizzo, Alice Giacobino, Luigi Chiusa, Michele Caraglia, Antonio Russo, John R. Mackey, Alfredo Falcone, Giuseppe Tonini   +16 more
openalex   +2 more sources

Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer. [PDF]

PLoS One
Park Y, Kim KS, Jo H, Kim HP, Kyung DS, Yoo Y, Min SK, Nam EM, Kim K.   +8 more
europepmc   +1 more source

A Population‐Based Matched Cohort Study of Extra‐Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy, Faria Ahmed, Michael Pugliese, Monica Taljaard, Parul Tandon, Priscilla Matthews, Gilaad G. Kaplan, Stephanie Coward, Charles N. Bernstein, Eric I. Benchimol, M. Ellen Kuenzig, Laura E. Targownik, Harminder Singh, on behalf of the Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC)   +13 more
wiley   +1 more source

Precision targeted-immunotherapy for BRAF V600E and MET-amplified biliary tract cancer: two case reports. [PDF]

Oncologist
He X, Xie S, Jia C, Wu X, Chen Z, Wang T.   +5 more
europepmc   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study [PDF]

Farshid Dayyani, Heide A. Stirnadel-Farrant, Jenny Hu, Yi‐An Lin, Nehemiah Kebede, Stephen J. Valerio, Daniel H. Ahn   +6 more
openalex   +1 more source